The global role of renal transplantation
Abstract
World Kidney Day on 8 March 2012 provides a chance to reflect on the success of kidney transplantation as a therapy for end-stage kidney disease that surpasses dialysis treatments both for the quality and quantity of life that it provides and for its cost effectiveness. Anything that is both cheaper and better, but is not actually the dominant therapy, must have other drawbacks that prevent replacement of all dialysis treatments by transplantation. The barriers to universal transplantation as the therapy for end-stage kidney disease include the economic limitations which, in some countries, place transplantation, appropriately, at a lower priority than public health fundamentals such as clean water, sanitation, and vaccination. Even in high-income countries, the technical challenges of surgery and the consequences of immunosuppression restrict the number of suitable recipients, but the major finite restrictions on kidney transplantation rates are the shortage of donated organs and the limited medical, surgical, and nursing workforces with the required expertise. These problems have solutions which involve the full range of societal, professional,
governmental, and political environments. World Kidney Day is a call to deliver transplantation therapy to the 1 million people a year who have a right to benefit.
References
Murray JE. Ronald Lee Herrick Memorial: June 15, 1931-December 27, 2010. Am J Transplant. 2011;11(3):419.
Clayton P, Excell L, Campbell S, McDonald S, Chadban S. ANZDATA Registry 2010 Report. Chapter 8. Transplantation [Internet]. Disponible en: http://www.anzdata.org.au/anzdata/AnzdataReport/33rdReport/Ch08.pdf [consulta: 29/11/2011].
Shimmura H, Tanabe K, Ishida H, Tokumoto T, Ishikawa N, Miyamoto N, et al. Lack of correlation between results of ABO-incompatible living kidney transplantation and anti-ABO blood type antibody titers under our current immunosuppression. Transplantation. 2005;80(7):985-8.
Peng A, Vo A, Jordan SC. Transplantation of the highly human leukocyte antigen–sensitized patient: long-term outcomes and future directions. Transplant Rev. 2006;20(3):146–56.
Warren DS, Montgomery RA. Incompatible kidney transplantation: lessons from a decade of desensitization and paired kidney exchange. Immunol Res. 2010;47(1-3):257-64.
Weber CL, Rush DN, Jeffery JR, Cheang M, Karpinski ME. Kidney transplantation outcomes in Canadian aboriginals. Am J Transplant. 2006;6(8):1875-81.
Gordon EJ, Ladner DP, Caicedo JC, Franklin J. Disparities in kidney transplant outcomes: a review. Semin Nephrol. 2010;30(1):81-9.
Collins JF. Kidney disease in Maori and Pacific people in New Zealand. Clin Nephrol. 2010;74(Suppl 1):S61-5.
Rizvi SA, Naqvi SA, Zafar MN, Hussain Z, Hashmi A, Hussain M, et al. Living related renal transplants with lifelong follow-up. A model for the developing world. Clin Nephrol. 2010;74(Suppl 1):S142-9.
Monteón FJ, Gómez B, Valdespino C, Chávez S, Sandoval M, Flores A, et al. The kidney transplant experience at Hospital de Especialidades, Centro Médico Nacional de Occidente, IMSS, Guadalajara México. Clin Transpl. 2003:165-74.
Jha V. Current status of end-stage renal disease care in South Asia. Ethn Dis. 2009;19(1 Suppl 1):S27-32.
Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725-30.
Sakhuja V, Sud K. End-stage renal disease in India and Pakistan: burden of disease and management issues. Kidney Int Suppl. 2003;(83):S115-8.
Rizvi SA, Naqvi SA, Zafar MN, Hussain Z, Hashmi A, Hussain M, et al. A renal transplantation model for developing countries. Am J Transplant. 2011;11(11):2302-7.
Sud K, Sakhuja V, Pandey R, Singh B, Kohli HS, Jha V, et al. Bioequivalance of two microemulsion preparations of cyclosporine in renal transplant recipient with stable graft function. Indian J Nephrol. 1999;9:83–91.
Meier-Kriesche HU, Kaplan B. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis. Transplantation. 2002;74(10):1377-81.
Kasiske BL, Snyder JJ, Matas AJ, Ellison MD, Gill JS, Kausz AT. Preemptive kidney transplantation: the advantage and the advantaged. J Am Soc Nephrol. 2002;13(5):1358-64.
World Health Organization. Global Knowledge Base on Transplantation (GKT) [Internet]. Disponible en: http://www.who.int/transplantation/knowledgebase/en/ [consulta: 29/11/2011].
Yeates K. Health disparities in renal disease in Canada. Semin Nephrol. 2010;30(1):12-8.
Alexander GC, Sehgal AR. Barriers to cadaveric renal transplantation among blacks, women, and the poor. JAMA. 1998;280(13):1148-52.
McDonald S. Incidence and treatment of ESRD among indigenous peoples of Australasia. Clin Nephrol. 2010 Nov;74(Suppl 1):S28-31.
Garcia-Garcia G, Renoirte-Lopez K, Marquez-Magaña I. Disparities in renal care in Jalisco, Mexico. Semin Nephrol. 2010;30(1):3-7.
Gordon EJ, Ladner DP, Caicedo JC, Franklin J. Disparities in kidney transplant outcomes: a review. Semin Nephrol. 2010;30(1):81-9.
WHO; Transplantation Society (TTS); Organización Nacional de Transplantes (ONT). Third WHO Global Consultation on Organ Donation and Transplantation: striving to achieve self-sufficiency, March 23–25, 2010, Madrid, Spain. Transplantation. 2011;91(Suppl 11):S27-8.
Bernat JL, D'Alessandro AM, Port FK, Bleck TP, Heard SO, Medina J, et al. Report of a National Conference on Donation after cardiac death. Am J Transplant. 2006;6(2):281-91.
Abraham G, John GT, Sunil S, Fernando EM, Reddy YN. Evolution of renal transplantation in India over the last four decades. NDT Plus. 2010;3:203-7.
Shimazono Y. The state of the international organ trade: a provisional picture based on integration of available information. Bull World Health Organ. 2007;85(12):955-62.
World Health Organization. Forty-fourth World Health Assembly, Geneva, 6-16 May 1991: resolutions and decisions, annexes [Internet]. Geneve: WHO, 1991. Disponible en: http://www.who.int/iris/handle/10665/173858 [consulta 29/11/2011].
World Health Organization. Who guiding principles on human cell, tissue and organ transplantation (33° World Health Assembly : May 2010) [Internet]. Disponible en: http://www.who.int/transplantation/Guiding_PrinciplesTransplantation_WHA63.22en.pdf [consulta 29/11/2011].
International Summit on Transplant Tourism and Organ Trafficking. The Declaration of Istanbul on Organ Trafficking and Transplant Tourism. Clin J Am Soc Nephrol. 2008;3(5):1227-31.
Delmonico FL, Domínguez-Gil B, Matesanz R, Noel L. A call for government accountability to achieve national self-sufficiency in organ donation and transplantation. Lancet. 2011;378(9800):1414-8.
United Nations. General Assembly. Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases [Internet]. 13 p. (A/RES/66/2). Disponible en: http://www.who.int/nmh/events/un_ncd_summit2011/political_declaration_en.pdf [consulta 29/11/2011].
